These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29417678)

  • 1. Re: Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false- negative cell-free DNA test result for trisomy 21.
    Dabi Y; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Feb; 51(2):278. PubMed ID: 29417678
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of low molecular weight heparin medication on plasma DNA in pregnant women.
    Grömminger S; Erkan S; Schöck U; Stangier K; Bonnet J; Schloo R; Schubert A; Prott EC; Knoll U; Stumm M; von Kalle C; Hofmann W
    Prenat Diagn; 2015 Nov; 35(11):1155-7. PubMed ID: 26248743
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21.
    Ma GC; Wu WJ; Lee MH; Lin YS; Chen M
    Ultrasound Obstet Gynecol; 2018 Feb; 51(2):276-277. PubMed ID: 28337808
    [No Abstract]   [Full Text] [Related]  

  • 5. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods.
    Conotte S; El Kenz H; De Marchin J; Jani JC
    Am J Obstet Gynecol; 2022 Sep; 227(3):539-541. PubMed ID: 35577013
    [No Abstract]   [Full Text] [Related]  

  • 7. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
    Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
    Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.
    García-Pérez L; Linertová R; Álvarez-de-la-Rosa M; Bayón JC; Imaz-Iglesia I; Ferrer-Rodríguez J; Serrano-Aguilar P
    Eur J Health Econ; 2018 Sep; 19(7):979-991. PubMed ID: 29249015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing Platform.
    Crea F; Forman M; Hulme R; Old RW; Ryan D; Mazey R; Risley MD
    Fetal Diagn Ther; 2017; 42(3):218-224. PubMed ID: 28171857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal testing.
    Harraway J
    Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results.
    Hartwig TS; Ambye L; Werge L; Weiergang MK; Nørgaard P; Sørensen S; Jørgensen FS
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():35-39. PubMed ID: 29804026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the provision of cell-free DNA screening for trisomy 21.
    Cuckle HS
    BJOG; 2021 Jan; 128(2):447. PubMed ID: 32892448
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of decreased serum levels of AFP in the detection of fetal trisomy in screening examinations of pregnant women].
    Lippert P; Ulbrichová Z; Benesová O
    Cesk Gynekol; 1989 Jul; 54(6):430-6. PubMed ID: 2477161
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.
    Norton ME; Brar H; Weiss J; Karimi A; Laurent LC; Caughey AB; Rodriguez MH; Williams J; Mitchell ME; Adair CD; Lee H; Jacobsson B; Tomlinson MW; Oepkes D; Hollemon D; Sparks AB; Oliphant A; Song K
    Am J Obstet Gynecol; 2012 Aug; 207(2):137.e1-8. PubMed ID: 22742782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More than a diagnosis.
    Thiele P; Berg SF; Farlow B
    Acta Paediatr; 2013 Dec; 102(12):1127-9. PubMed ID: 24102789
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.